EyePoint Pharmaceuticals Inc

NASDAQ: EYPT
Share price (5/31/24): $10.71
Market cap (5/31/24): $558 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Cormorant Asset Management, LP, Chen Bihua, Cormorant Global Healthcare Master Fund, LP

Adage Capital Management, L.P.

News Filter

Investor Presentation

Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments

Announces Topline Data From the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy

Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments

Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC